AKT1 and gastric cancer: The induced antibodies, including those in the patient referenced in this study, could inhibit intracellular Her-2/neu phosphorylation and the downstream phosphorylation of the Akt (Thr 308) signaling pathway in gastric cancer cells (NCI-N87) [10].